Samba O. Sow

Bamako, BKO, ML

Expertise in

conditions

Bamako, BKO, ML

OverviewLocationsClinical Research

Overview

Samba Sow practices in Bamako, Mali. Dr. Sow is highly rated in 18 conditions, according to our data. His top areas of expertise are Diarrhea, Meningitis, Bacterial Meningitis, and Ebola Virus Disease.

His clinical research consists of co-authoring 260 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Bamako, BKO, Mali

Other Locations

Mali

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2, Observer-blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of Two Formulations of Investigational Meningococcal Groups ACYWX Conjugate Vaccine, Administered to Healthy Malian Children 12-16 Months of Age

Enrollment Status: Completed

Publish Date: May 25, 2025

Intervention Type: Biological

Study Phase: Phase 2

LAKANA , a Cluster-randomized, Double-blinded, Parallel Group, Controlled Trial, Testing the Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in Rural Mali.

Enrollment Status: Completed

Publish Date: May 21, 2025

Intervention Type: Drug

Study Drug: Azithromycin

Study Phase: Phase 3

A Phase 3 Trial to Evaluate the Safety, Immunogenicity, and Non-Interference With Concomitant Routine Vaccines, of a Meningococcal Serogroup ACYWX Conjugate Vaccine (NmCV-5) in Comparison With MenACWY-TT Conjugate Vaccine in Healthy Malian Infants

Enrollment Status: Completed

Publish Date: April 17, 2025

Intervention Type: Biological

Study Phase: Phase 3

Phase 3, Observer-blind, Randomized, Active Controlled Trial to Assess the Safety of an Investigational Meningococcal Serogroups ACYWX Conjugate Vaccine (NmCV-5) and Compare Its Immunogenicity to a Licensed Meningococcal Serogroups ACYW Conjugate Vaccine (Menactra®), in Healthy Subjects 2 to 29 Years of Age

Enrollment Status: Completed

Publish Date: July 27, 2021

Intervention Type: Biological

Study Drugs: NmCV-5, Menactra

Study Phase: Phase 3

View 3 Less Clinical Trials

259 Total Publications

Correction: Comparison of causes of stillbirth and child deaths as determined by verbal autopsy and minimally invasive tissue sampling.

Journal: PLOS global public health

Published: December 05, 2025

View All 259 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sow's expertise for a condition

ConditionClose